Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote — —   —
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  0.6405 03:44 PM EST  
    Day High 0.6799 10:42 AM EST
    Range 0.04  
    Volume 664,379  
    30-Day Avg Vol 1.45 M
    Difference -54.24%  
    Market Cap 81.69 M  
    Mkt Cap Chg 757,629  
    Shares Out 126.27 M  
    % Shrs Traded 0.53%  
    1yr EPS Est -0.38  
    52-Wk Low 0.3251
    52-Wk High 2.40
    Range 2.07  
    Prev Close 0.641 2/8/10  
    Today's Open 0.65  
    Change 1.40%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date —
    Div Date —
    Short Interest 16.9 M

    Performance Details

    Revenue (LFY) 4.60 M  
    Earnings (LFY) -39.11 M  
    Earnings (MRQ) -7.19 M  
    Next Earn Est -0.06  
    Next Earnings 03/08/2010
    EPS (TTM) -0.31  
    1yr EPS Growth -26.67%  
    P/E Ratio (TTM) —  
    P/E Ratio (Fwd) -1.00  
    PEG Ratio —  
    Return on Equity -157.10  
    Beta 1.04  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
    More Details
  • Advertisement

  • Set and Manage Alerts

    Manage Alerts
    Alert me if
    Set Alert

  • Blog Posts: DSCO

    Blogs are not currently available for dsco.

    View all blogs at BloggingStocks.

  • Related Information: DSCO

    Company Overview: DSCO

    If you're waiting to exhale, Discovery Laboratories may be able to help. The biotechnology company focuses on treatments for respiratory disorders, particularly for babies in intensive care. Its lead candidate, ... View Full Description

    View Full Company Overview

    Earnings Analysis: DSCO

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter -0.06 3/8/10 — — —
    —
    Last Quarter -0.06 9/30/09 -0.06 9/30/09 0.00
    Met
    2 Quarters Ago -0.09 6/30/09 -0.07 6/30/09 0.02
    Beat
    View Full Earnings Analysis

    Financials: DSCO

    Income Statement
      Quarterly - 09/30/2009 Annual - 2008
    Total Revenue 0.00 4.60 M
    Gross Profit — 2.38 M
    Operating Income -6.55 M -38.39 M
    Net Income -7.19 M -39.11 M
    Financials: Balance Sheet | Cash Flow View All Financials

    Related Companies: DSCO

    Sector: Healthcare      Industry: Drugs
    Symbol Name Price Change
    ABT ABBOTT LABS 53.35 0.00 0.00%
    FRX FOREST LABS INC 28.98 0.20 0.69%